The purpose of this core is to provide a phenotypic validation of the genetic manipulation made under several subprojects. This core will provide neurobiological evaluations of transgenic and partial trisomic lines constructed to provide over-expression of single or multiple genes found on human chromosome 21. Behavioral, histological and neurochemical and studies will be carried out to identify the specific neurobiological effects of over-expression of these genes to determine what genes singly or in combination may account for the mental retardation or other neurobiological outcome exhibited in Down syndrome. The core will also provide an assessment of cholinergic and glutamatergic development in Ts65Dn mice and will evaluate the effects of the pharmacological manipulations in Dr. Moran's project. The proposed core represents a significant expansion from what had existed under the previous program. This expansion of the core is consistent with the changing priorities and focus of the program. The core has two components which take advantage of the expertise of the investigators. The behavioral and pre-synaptic neurochemical evaluations will be carried out in Dr. Moran's laboratory within the Department of Psychiatry at Johns Hopkins. Dr. Blue will assess brain morphology and immunohistochemical techniques at the Kennedy Krieger Institute.

Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
13
Fiscal Year
2002
Total Cost
$208,891
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Singh, Nandini; Dutka, Tara; Devenney, Benjamin M et al. (2015) Acute upregulation of hedgehog signaling in mice causes differential effects on cranial morphology. Dis Model Mech 8:271-9
Bean, Lora J H; Allen, Emily G; Tinker, Stuart W et al. (2011) Lack of maternal folic acid supplementation is associated with heart defects in Down syndrome: a report from the National Down Syndrome Project. Birth Defects Res A Clin Mol Teratol 91:885-93
Locke, Adam E; Dooley, Kenneth J; Tinker, Stuart W et al. (2010) Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with Down syndrome. Genet Epidemiol 34:613-23
Freeman, S B; Torfs, C P; Romitti, P A et al. (2009) Congenital gastrointestinal defects in Down syndrome: a report from the Atlanta and National Down Syndrome Projects. Clin Genet 75:180-4
Lin, Yan; Tseng, George C; Cheong, Soo Yeon et al. (2008) Smarter clustering methods for SNP genotype calling. Bioinformatics 24:2665-71
Freeman, Sallie B; Bean, Lora H; Allen, Emily G et al. (2008) Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project. Genet Med 10:173-80
Parsons, Trish; Ryan, Timothy M; Reeves, Roger H et al. (2007) Microstructure of trabecular bone in a mouse model for Down syndrome. Anat Rec (Hoboken) 290:414-21
Roper, Randall J; St John, Heidi K; Philip, Jessica et al. (2006) Perinatal loss of Ts65Dn Down syndrome mice. Genetics 172:437-43
Maslen, Cheryl L; Babcock, Darcie; Robinson, Susan W et al. (2006) CRELD1 mutations contribute to the occurrence of cardiac atrioventricular septal defects in Down syndrome. Am J Med Genet A 140:2501-5
Richtsmeier, Joan T; Aldridge, Kristina; DeLeon, Valerie B et al. (2006) Phenotypic integration of neurocranium and brain. J Exp Zool B Mol Dev Evol 306:360-78

Showing the most recent 10 out of 114 publications